Literature DB >> 2380375

Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri group".

R A Whiley1, H Fraser, J M Hardie, D Beighton.   

Abstract

A biochemical scheme was developed by which strains of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus can reliably be distinguished from within the "Streptococcus milleri group." Strains identified as S. intermedius were differentiated by the ability to produce detectable levels of alpha-glucosidase, beta-galactosidase, beta-D-fucosidase, beta-N-acetylgalactosaminidase, beta-N-acetylglucosaminidase, and sialidase with 4-methylumbelliferyl-linked fluorogenic substrates in microdilution trays after 3 h of incubation at 37 degrees C, together with the production of hyaluronidase. Strains of S. constellatus and S. anginosus were differentiated by the production of alpha-glucosidase and hyaluronidase by the former and the production of beta-glucosidase by the latter. The majority of strains of the S. milleri group obtained from dental plaque were identified as S. intermedius, as were most strains isolated from abscesses of the brain and liver. Strains of S. constellatus and S. anginosus were from a wider variety of infections, both oral and nonoral, than were strains of S. intermedius, with the majority of strains from urogenital infections being identified as S. anginosus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2380375      PMCID: PMC267976          DOI: 10.1128/jcm.28.7.1497-1501.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  MENINGITIS DUE TO STREPTOCOCCUS ANGINOSUS (LANCEFIELD GROUP F).

Authors:  J A KOEPKE
Journal:  JAMA       Date:  1965-08-30       Impact factor: 56.272

2.  [Pathogenic strains of Streptococcus viridans; streptocci found in dental abscesses and infiltrates in the region of the oral cavity].

Authors:  O GUTHOF
Journal:  Zentralbl Bakteriol Orig       Date:  1956-09

3.  Effect of a partially chemically defined diet on normal human fecal flora.

Authors:  H R Attebery; V L Sutter; S M Finegold
Journal:  Am J Clin Nutr       Date:  1972-12       Impact factor: 7.045

4.  Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms.

Authors:  R F Smith; N P Willett
Journal:  Appl Microbiol       Date:  1968-09

5.  Isolation and physiological characterization of Streptococcus milleri strains from human dental plaque.

Authors:  T Yakushiji; M Katsuki; A Yoshimitsu; J Mizuno; M Inoue
Journal:  Microbios       Date:  1988

6.  The isolation of streptococci from human faeces.

Authors:  P F Unsworth
Journal:  J Hyg (Lond)       Date:  1980-08

7.  Clinical significance of Streptococcus milleri.

Authors:  P Van der Auwera
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

8.  Streptococci and aerococci associated with systemic infection in man.

Authors:  M T Parker; L C Ball
Journal:  J Med Microbiol       Date:  1976-08       Impact factor: 2.472

9.  Studies on streptococci resembling Streptococcus milleri and on an associated surface-protein antigen.

Authors:  R Lütticken; U Wendorff; D Lütticken; E A Johnson; L W Wannamaker
Journal:  J Med Microbiol       Date:  1978-11       Impact factor: 2.472

10.  Physiological differentiation of viridans streptococci.

Authors:  R R Facklam
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

View more
  86 in total

1.  PCR-Based methods for genotyping viridans group streptococci.

Authors:  S Alam; S R Brailsford; R A Whiley; D Beighton
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Macrorestriction fingerprinting of "Streptococcus milleri" group bacteria by pulsed-field gel electrophoresis.

Authors:  K L Bartie; M J Wilson; D W Williams; M A Lewis
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes.

Authors:  Anders Jensen; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

Review 4.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

5.  Comparing Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Phenotypic and Molecular Methods for Identification of Species within the Streptococcus anginosus Group.

Authors:  Raquel Arinto-Garcia; Marcos Daniel Pinho; João André Carriço; José Melo-Cristino; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2015-09-09       Impact factor: 5.948

6.  Use of rapid carbohydrate utilisation test for identifying "Streptococcus milleri group".

Authors:  J M Whitworth; P W Ross; I R Poxton
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

7.  Survey of emm-like gene sequences from pharyngeal isolates of group C and group G streptococci collected in Spain.

Authors:  Sebastián Albertí; Cesar García-Rey; María Isabel García-Laorden; Rafael Dal-Ré; Juan García-de-Lomas
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Species-level molecular identification of invasive "Streptococcus milleri" group clinical isolates by nucleic acid sequencing in a centralized regional microbiology laboratory.

Authors:  Peter Daley; Deirdre L Church; Daniel B Gregson; Sameer Elsayed
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

9.  Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.

Authors:  Margot E Grinwis; Christopher D Sibley; Michael D Parkins; Christina S Eshaghurshan; Harvey R Rabin; Michael G Surette
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

10.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.